TaiMed Biologics notifies Theratechnologies of preliminary results for phase III trial of ibalizumab Nov. 11, 2016 No Comments
Anti-alpha4beta7 MAb regimen leads to SIV suppression long after treatment in monkeys Nov. 2, 2016 No Comments
Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection Oct. 7, 2016 No Comments
RSS